This section is for people at Signatory Institutions and people at organizations that want to become Signatory Institutions. It includes information on becoming a Signatory Institution, as well as Quickguides on all tasks associated with being a Signatory Institution.
Institutions that are part of the NCI Division of Cancer Prevention (DCP) Phase 0/I/II Cancer Prevention Clinical Trials Program/Cancer Prevention Clinical Trials Network (Consortia/CP-CTNet) have different processes for gaining access to IRBManager and obtaining CIRB-approved documents. For more information, go to Navigating the CIRB as a Consortia/CP-CTNet Site.
In addition to the information for CIRB institutions, additional resources include: